House dust mite allergen avoidance and self-management in allergic patients with asthma: Randomised controlled trial

British Journal of General Practice

Volumn 57, Issue 536, 2007, Pages 184-190

  De Vries, Marjolein P ^a   Van den Bemt, Lisette ^b   Aretz, Karen ^a   Thoonen, Bart P A ^b   Muris, Jean W M ^a   Kester, Arnold D M ^a   Cloosterman, Sonja ^a   van Schayck, C P Onno ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergy; Asthma; Corticosteroids; House dust mites; Inhalation; Self management

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; PLACEBO; PREDNISOLONE;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; BED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DYSPNEA; FEMALE; FOLLOW UP; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF CARE; SYMPTOM; WHEEZING;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ASTHMA; BEDDING AND LINENS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; PYROGLYPHIDAE; SELF ADMINISTRATION; TICK CONTROL; TREATMENT OUTCOME;

EID: 33847654178     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142(2): 434-457.
2. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142(4): 832-836.
3. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticostetoid, budesonide, in newly detected asthma. N Engl J Med 1991; 325(6): 388-392.
4. Kerstjens HA, Brand PL, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med 1992; 327(20): 1413-1419.
5. Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118(10): 770-778.
6. Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003; 112(3): 469-478.
7. Haahtela T, Järvinen M, Kava TT, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331(11): 700-705.
8. Thoonen BP, Schermer TR, van den Boom G, et al. Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003; 58(1): 30-36.
9. Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2002; 3: CD004107.
10. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 1996; 312(7033): 748-752.
11. Beasley R, Cushley M, Holgate ST. A self management plan in the treatment of adult asthma. Thorax 1989; 44(3): 200-204.
12. Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax 2004; 59(2): 94-99.
13. Schermer TR, Thoonen BP, van den Boom G, et al. Randomized controlled economic evaluation of asthma self-management in primary health care. Am J Respir Crit Care Med 2002; 166(8): 1062-1072.
14. Colloff MJ, Ayres J, Carswell F, et al. The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy 1992; 22(Suppl 2): 1-28.
15. Custovic A, Taggart SCO, Francis HC, et al. Exposure to house dust mite allergens and clinical activity of asthma. J Allergy Clin Immunol 1996; 98(1): 64-72.
16. Hegarty JM, Jessop WJ, Warner JA, Warner JO. The effect of a bed covering system on airborne levels of house dust mite allergen. Eur Respir J 1997; 10: 361-366.
17. Walshaw MJ, Evans CC. Allergen avoidance in house dust mite sensitive adult asthma. Q J Med 1986; 58(226): 199-215.
18. Owen S, Morganstern M, Hepworth J, Woodcock A. Control of house dust mite antigen in bedding. Lancet 1990; 335(8686): 396-397.
19. Cloosterman SGM, Hofland ID, van der Heide S, et al. Long-term effects of matress-covers on house dust mite (Der-p-I). Eur Respir J 1995; 8(S19): 499.
20. Van der Heide S, Kauffman HF, Dubois AE, de Monchy JG. Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers. Eur Respir J 1997; 10(6): 1217-1223.
21. Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004; 4: CD001187.
22. Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349(3): 225-236.
23. Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, et al. Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study. Thorax 2002; 57(9): 784-790.
24. Halken S, Host A, Niklassen U, et al. Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol 2003; 111(1): 169-176.
25. Cloosterman SGM, Holland ID, Lukassen HGM, et al. House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: a possible delay in the manifestation of clinical asthma? J Allergy Clin Immunol 1997; 100(3): 313-319.
26. Cloosterman SG, Schermer TR, Bijl-Hofland ID, et al. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids. Clin Exp Allergy 1999; 29(10): 1336-1346.
27. Van den Bemt L, van Knapen L, de Vries MP, et al. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients. J Allergy Clin Immunol 2004; 114(4): 858-862.
28. Geijer RMM, Van Hensbergen W, Bottema BJAM, et al. NHG-Standaard Astma bij Volwassenen: Behandeling (NHG Guideline on Asthma in Adults: Treatment). Huisarts Wet 2001; 44(4): 153-164.
29. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MA: National Institute of Health, 2002.
30. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996; 42(6): 697-705.
31. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14(4): 902-907.
32. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org (accessed 6 Feb 2007).
33. Juniper EF, Stahl E, O'Byrne PM. Minimal important difference for the asthma control questionnaire. Am J Respir Crit Care Med 2001; 163: A642.
34. Van Strien RT, Koopman LP, Kerkhof M, et al. Mattress encasings and mite allergen levels in the Prevention and Incidence of Asthma and Mite Allergy study. Clin Exp Allergy 2003; 33(4): 490-495.
35. Platts-Mills TAE, Vervloet D, Thomas WR, et al. Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997; 100(6 Pt 1): S1-S24.
36. Van Strien RT, Verhoeff AP, van Wijnen JH, et al. Der p I concentrations in mattress surface and floor dust collected from infants' bedrooms. Clin Exp Allergy 1995; 25(12): 1184-1189.
37. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, et al. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy 2005; 60(7): 888-893.
38. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2002; 3: CD001117.